Effective sirolimus treatment for refractory spindle cell haemangioma
C.B. Ho
Department of Radiation Oncology, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan
Search for more papers by this authorK. Hsieh
Department of Medical Imaging, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan
Department of Radiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
Search for more papers by this authorW.Y. Chen
Department of Pathology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan
Search for more papers by this authorY.T. Lin
Department of Dermatology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan
Search for more papers by this authorJ.F. Chiou
Department of Radiation Oncology, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan
Department of Radiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
Taipei Cancer Center, Taipei Medical University, Taipei, Taiwan
The Ph.D. Program for Translational Medicine, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei Medical University, Taipei, Taiwan
Search for more papers by this authorH.L. Lee
Department of Radiation Oncology, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan
Taipei Cancer Center, Taipei Medical University, Taipei, Taiwan
The Ph.D. Program for Translational Medicine, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei Medical University, Taipei, Taiwan
Search for more papers by this authorH.S. Shiah
Taipei Cancer Center, Taipei Medical University, Taipei, Taiwan
Division of Hematology and Oncology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan
Graduate Institute of Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
Search for more papers by this authorC.B. Ho
Department of Radiation Oncology, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan
Search for more papers by this authorK. Hsieh
Department of Medical Imaging, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan
Department of Radiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
Search for more papers by this authorW.Y. Chen
Department of Pathology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan
Search for more papers by this authorY.T. Lin
Department of Dermatology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan
Search for more papers by this authorJ.F. Chiou
Department of Radiation Oncology, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan
Department of Radiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
Taipei Cancer Center, Taipei Medical University, Taipei, Taiwan
The Ph.D. Program for Translational Medicine, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei Medical University, Taipei, Taiwan
Search for more papers by this authorH.L. Lee
Department of Radiation Oncology, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan
Taipei Cancer Center, Taipei Medical University, Taipei, Taiwan
The Ph.D. Program for Translational Medicine, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei Medical University, Taipei, Taiwan
Search for more papers by this authorH.S. Shiah
Taipei Cancer Center, Taipei Medical University, Taipei, Taiwan
Division of Hematology and Oncology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan
Graduate Institute of Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan
Search for more papers by this author
References
- 1Perkins P, Weiss SW. Spindle cell hemangioendothelioma. An analysis of 78 cases with reassessment of its pathogenesis and biologic behavior. Am J Surg Pathol 1996; 20: 1196–204.
- 2Kramer D, Downey C, Vargas P, Castro A. Multifocal spindle cell hemangioma: report of two cases. Indian J Dermatol Venereol Leprol 2016; 82: 93–5.
- 3Setoyama M, Shimada H, Miyazono N et al. Spindle cell hemangioendothelioma: successful treatment with recombinant interleukin-2. Br J Dermatol 2000; 142: 1238–9.
- 4Riou S, Morelon E, Guibaud L et al. Efficacy of rapamycin for refractory hemangioendotheliomas in Maffucci's syndrome. J Clin Oncol 2012; 30: e213–15.
- 5Adams DM, Trenor CC 3rd, Hammill AM et al. Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies. Pediatrics 2016; 137: e20153257.
- 6Shah S, Verma P. Overview of pregnancy in renal transplant patients. Int J Nephrol 2016; 2016: 4539342.
- 7Fogel AL, Hill S, Teng JM. Advances in the therapeutic use of mammalian target of rapamycin (mTOR) inhibitors in dermatology. J Am Acad Dermatol 2015; 72: 879–89.
